Monte Rosa Therapeutics is focused on developing molecular glue degraders (MGDs) that target undruggable proteins for therapeutic purposes, particularly in immunology and inflammation
Monte Rosa Therapeutics is focused on developing molecular glue degraders (MGDs) that target undruggable proteins for therapeutic purposes, particularly in immunology and inflammation.